Publication | Open Access

Comprehensive Clinical and Genetic Characterization of Hyperprogression Based on Volumetry in Advanced Non–Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor

Prognostic BiomarkersComprehensive ClinicalMedicineImmunologyPathologyGenetic CharacterizationImmune Checkpoint InhibitorCancer TreatmentMolecular DiagnosticsOncologyRadiation OncologyLung Cancer